Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
Operator: Welcome ladies and gentlemen to the Fourth Quarter and Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 8,963,000 | $36,658,670 | -28% | 4.06% |
| 2. | AQR Capital Management Cliff Asness | 1,190,993 | $4,871,162 | -23% | 0% |
| 3. | D E Shaw D. E. Shaw | 966,872 | $3,954,507 | -11% | 0% |
| 4. | Millennium Management Israel Englander | 946,214 | $3,870,015 | -29% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 877,900 | $3,590,611 | -11% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.56 | 3,000 | Large Shareholder | 76,382 | 2022-11-21 | Filing | |
| $2.57 | 3,000 | Large Shareholder | 73,382 | 2022-11-18 | Filing | |
| $4.76 | 3,000 | Director | 70,854 | 2022-08-12 | Filing | |
| $4.80 | 5,000 | Director | 25,547 | 2022-08-12 | Filing | |
| $6.10 | 3,000 | Large Shareholder | 70,382 | 2022-05-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.28 | 17,972 | Large Shareholder | 59,007,134 | 2024-01-10 | Filing | |
| $4.37 | 197,921 | Large Shareholder | 59,025,106 | 2024-01-09 | Filing | |
| $4.28 | 17,972 | Large Shareholder | 59,007,134 | 2024-01-10 | Filing | |
| $4.37 | 197,921 | Large Shareholder | 59,025,106 | 2024-01-09 | Filing | |
| $2.07 | 25,000 | Large Shareholder | 59,223,027 | 2023-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,377,756 | $54,715,024 | 0% | |
| 2. | 5,360,727 | $21,925,373 | 0% | |
| 3. | 5,198,187 | $21,260,584 | 0% | |
| 4. | 2,511,426 | $10,271,732 | 0% | |
| 5. | 1,696,868 | $6,940,900 | 0% |
News See All
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions].
12 Best Micro Cap Stocks To Invest In
In this piece, we will take a look at the 12 best micro cap stocks to invest in.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions].
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen to the First Quarter of Fiscal Year 2023 Earnings Conference Call for the Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2022 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen to the Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Organogenesis Holdings Inc.
5 Most Undervalued Penny Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 5 most undervalued penny stocks to buy according to hedge funds.
10 Best 52-Week Low Small-Cap Stocks to Buy Now
In this article, we discuss the 10 best 52-week low small-cap stocks to buy now.
Here is What Hedge Funds Think About Organogenesis Holdings Inc. (ORGO)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Hedge Fund and Insider Trading News: Bill Ackman, David Tepper, Ray Dalio, Organogenesis Holdings Inc (ORGO), Silicon Laboratories (SLAB), and More
Bill Ackman made a big bet on himself even as some investors were second-guessing the future of his hedge fund, Pershing Square Capital Management. So far, it’s paying off.
Billionaire Hedge Funds
